TPST Tempest Therapeutics
Tempest Therapeutics earnings company data as of 10:00 AM ET 10/23
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | — | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 13 Aug | EPS | — | -0.34 | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by TPST's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $1M bought by 1 insider
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Matthew Angel CEOBuy$500K 231,482 shares at $2.16 New stakeTraded Mar 24 Filed Jun 23
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| DEFA14A | CURRENT REPORT | Filing Doc | |
| 8-K | 5.07,8.01 | Filing Doc | |
| 8-K | 5.02,7.01,9.01 | Filing Doc | |
| 424B3 | PROSPECTUS | Filing Doc | |
| 8-K | 1.01,5.02,7.01,9.01 | Filing Doc | |
| 8-K | 1.01,7.01,9.01 | Filing Doc | |
| 8-K | 5.07,8.01 | Filing Doc | |
| DEFA14A | Filing Doc | ||
| 8-K | 1.01,3.02,9.01 | Filing Doc | |
| 424B3 | Filing Doc | ||
| 8-K | 5.02 | Filing Doc | |
| S-1 | Filing Doc | ||
| 8-K | 5.07,8.01 | Filing Doc | |
| DEFA14A | Filing Doc | ||
| 8-K | 1.01,3.02,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.07,8.01 | Filing Doc | |
| DEFA14A | Filing Doc | ||
| 8-K | 1.01,7.01,9.01 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| 424B3 | Filing Doc | ||
| 8-K | 5.07 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| 8-K | 5.02,7.01,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.